With over 90% of our sales and 100% of our pipeline dedicated to the central nervous system (CNS), we are committed to advancing treatment options for patients with CNS disorders. Our new website brings this to life, spotlighting how we are transforming the future of CNS care in Europe and beyond.
As Europe’s CNS specialist, we now cover 98% of the European CNS market through our own commercial organizations, with a direct presence in 23 countries in Europe, four outside of Europe, and a growing international footprint. Our centre of excellence – Neuraxpharm Healthtech – is continuously developing innovative solutions to address the complex unmet needs of our CNS patients.
Explore our new website to discover…
• Our innovation-led strategy, with a deep dive into our CNS-dedicated R&D and pipeline activities
• Why Neuraxpharm is the partner of choice in CNS – with over 40 years of expertise, from product development to commercialization
• A brand-new resource hub on CNS pathologies, underlining our dedication to the CNS community
We are proud to be shaping the future of CNS care through innovation.